LOADING
Comparing Visa Inc (V) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $606.3B | $533.0B |
| P/E Ratio | 27.8 | 25.6 |
| Forward P/E | 24.5 | 19.1 |
| PEG Ratio | 1.67 | 2.88 |
| EPS | $11.48 | $8.64 |
| Revenue Growth (YoY) | 17.1% | 9.9% |
| Profit Margin | 51.7% | 21.8% |
| Return on Equity | 60.4% | 26.4% |
| Dividend Yield | 0.81% | 2.35% |
| Beta | 0.78 | 0.26 |
| 52-Week High | $373.33 | $251.71 |
| 52-Week Low | $293.89 | $142.16 |
| Volume | -- | -- |
Visa Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.